<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108779-903</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Economics of tobacco control research initiative: Operating costs for capacity building</narrative>
   <narrative xml:lang="FR">Initiative de recherche sur la dimension &#xE9;conomique de la lutte antitabac : co&#xFB;ts d&#x2019;exploitation pour le renforcement des capacit&#xE9;s</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Fiscal policies (primarily taxation) for tobacco control have been widely recognized as the most effective measures to curb tobacco consumption and prevent tobacco-related diseases. They also have the effect of reducing household poverty and increasing national revenues. However, most low and middle-income countries (LMICs) have not effectively implemented such policies to date. Common barriers include competing health and development priorities and a lack of knowledge about country or region specific health and economic burdens related to tobacco, and the potential benefits of appropriate policies. Industry opposition and commonly-held (but misinformed) beliefs about the economic benefits of the tobacco industry also present barriers to tobacco control policy in many LMICs.  

Through this initiative, Cancer Research UK and IDRC aim to address the development challenges posed by tobacco use in LMICs. The countries where research will be carried out will be determined through the competitive research call process. By supporting research on the economics of tobacco control in LMICs, this five-year initiative will allow the generation of the local evidence that is acutely needed to implement fiscal and policy solutions for effective tobacco control. Beyond the generation of evidence, this initiative will support collaborations between multiple institutions within countries or regions to enable research teams to actively engage in policy dialogue and policymaking processes. Local evidence will provide the context-specific information and tools needed to help countries leap forward with tobacco-control policy and contribute to SDG targets with respect to health and economic empowerment. 

This project will cover the human resource cost of a full-time senior program officer to manage the project, and associated travel and office costs over the course of the five-year initiative. The staff under the initiative will be responsible for the delivery and monitoring of the research projects selected through the competitive call, as well as communications about the initiative, and reporting to the governance committee.</narrative>
   <narrative xml:lang="FR">Les politiques fiscales (surtout la fiscalit&#xE9;) antitabac ont &#xE9;t&#xE9; largement reconnues comme les mesures les plus efficaces afin de r&#xE9;duire la consommation de tabac et de pr&#xE9;venir les maladies connexes. Elles ont &#xE9;galement pour effet de diminuer la pauvret&#xE9; des m&#xE9;nages et d&#x2019;augmenter les recettes nationales. Toutefois, la plupart des pays &#xE0; faible revenu et &#xE0; revenu interm&#xE9;diaire PFR-PRI n&#x2019;ont toujours pas instaur&#xE9; de telles politiques. Les obstacles les plus souvent cit&#xE9;s sont les priorit&#xE9;s concurrentes en mati&#xE8;re de sant&#xE9; et de d&#xE9;veloppement ainsi que le manque de connaissances quant aux pressions exerc&#xE9;es sur le syst&#xE8;me de sant&#xE9; et l&#x2019;&#xE9;conomie des pays ou r&#xE9;gions d&#xE9;coulant de la consommation de tabac, et aux possibles avantages de politiques appropri&#xE9;es. L&#x2019;opposition de l&#x2019;industrie et des croyances persistantes (quoiqu&#x2019;erron&#xE9;es) au sujet des avantages &#xE9;conomiques de l&#x2019;industrie du tabac pr&#xE9;sentent &#xE9;galement des obstacles aux politiques de lutte antitabac dans plusieurs PFR-PRI. 

Gr&#xE2;ce &#xE0; cette initiative, Cancer Research UK et le CRDI souhaitent s&#x2019;attaquer aux d&#xE9;fis de d&#xE9;veloppement pos&#xE9;s par le tabagisme dans les PFR-PRI. Les pays o&#xF9; la recherche aura lieu seront d&#xE9;termin&#xE9;s gr&#xE2;ce au processus concurrentiel d&#x2019;appel &#xE0; propositions de recherche. En appuyant la recherche sur la dimension &#xE9;conomique de la lutte antitabac dans les PFR-PRI, cette initiative sur cinq ans contribuera &#xE0; la production des donn&#xE9;es probantes locales n&#xE9;cessaires &#xE0; l&#x2019;application de solutions financi&#xE8;res et strat&#xE9;giques pour une efficace lutte antitabac. Outre la production de donn&#xE9;es probantes, cette initiative soutiendra aussi les collaborations entre plusieurs institutions dans un m&#xEA;me pays ou une m&#xEA;me r&#xE9;gion afin de permettre aux &#xE9;quipes de recherche de participer activement au dialogue sur les politiques et sur le processus d&#x2019;&#xE9;laboration de politiques. Des donn&#xE9;es probantes locales fourniront les renseignements et les outils adapt&#xE9;s au contexte, n&#xE9;cessaires pour aider les pays &#xE0; promouvoir les politiques antitabac et contribueront aux cibles des ODD en mati&#xE8;re de sant&#xE9; et d&#x2019;autonomisation &#xE9;conomique. 

Ce projet couvrira la r&#xE9;mun&#xE9;ration d&#x2019;un administrateur principal de programme &#xE0; temps plein qui g&#xE9;rera le projet, ainsi que les d&#xE9;penses de d&#xE9;placement et de bureau connexes pendant l&#x2019;initiative de cinq ans. Le personnel de l&#x2019;initiative sera responsable de la r&#xE9;alisation et du suivi des projets de recherche s&#xE9;lectionn&#xE9;s au moyen de l&#x2019;appel concurrentiel, ainsi que des communications au sujet de l&#x2019;initiative et des rapports au comit&#xE9; de gouvernance.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Cancer Research UK</narrative>
  </participating-org>
  <participating-org role="2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2017-09-14" type="2"></activity-date>
  <activity-date iso-date="2022-09-14" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12110" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="1" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-12-12"></transaction-date>
   <value currency="CAD" value-date="2017-12-12">10575.29</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-04-12"></transaction-date>
   <value currency="CAD" value-date="2018-04-12">32201.91</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-28"></transaction-date>
   <value currency="CAD" value-date="2019-03-28">-1318.03</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-29"></transaction-date>
   <value currency="CAD" value-date="2019-03-29">-4651.87</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-05-06"></transaction-date>
   <value currency="CAD" value-date="2019-05-06">11862.31</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-10-28"></transaction-date>
   <value currency="CAD" value-date="2019-10-28">15506.28</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-05-11"></transaction-date>
   <value currency="CAD" value-date="2020-05-11">27174.77</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-12-12"></transaction-date>
   <value currency="CAD" value-date="2017-12-12">3064.71</value>
   <provider-org>
    <narrative xml:lang="EN">Cancer Research UK</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-04-12"></transaction-date>
   <value currency="CAD" value-date="2018-04-12">9332.09</value>
   <provider-org>
    <narrative xml:lang="EN">Cancer Research UK</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-28"></transaction-date>
   <value currency="CAD" value-date="2019-03-28">-381.97</value>
   <provider-org>
    <narrative xml:lang="EN">Cancer Research UK</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-29"></transaction-date>
   <value currency="CAD" value-date="2019-03-29">-1348.13</value>
   <provider-org>
    <narrative xml:lang="EN">Cancer Research UK</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-05-06"></transaction-date>
   <value currency="CAD" value-date="2019-05-06">3437.69</value>
   <provider-org>
    <narrative xml:lang="EN">Cancer Research UK</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-10-28"></transaction-date>
   <value currency="CAD" value-date="2019-10-28">4493.72</value>
   <provider-org>
    <narrative xml:lang="EN">Cancer Research UK</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-05-11"></transaction-date>
   <value currency="CAD" value-date="2020-05-11">7875.23</value>
   <provider-org>
    <narrative xml:lang="EN">Cancer Research UK</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="0"></conditions>
 </iati-activity>
</iati-activities>
